Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2024-10-03 Sale |
2024-10-03 9:55 pm |
BioXcel Therapeutics Inc. | BTAI | Wiley Matthew T. Chief Commercial Officer |
6,272 | $0.55 | $3,450 | 19,011 (Direct) |
View |
| 2024-09-16 Sale |
2024-09-17 7:18 pm |
BioXcel Therapeutics Inc. | BTAI | Wiley Matthew T. Chief Commercial Officer |
215 | $0.6908 | $149 | 11,533 (Direct) |
View |
| 2024-06-17 Sale |
2024-06-18 9:26 pm |
BioXcel Therapeutics Inc. | BTAI | Wiley Matthew T. Chief Commercial Officer |
244 | $1.2627 | $308 | 11,748 (Direct) |
View |
| 2024-04-04 Sale |
2024-04-08 7:31 pm |
BioXcel Therapeutics Inc. | BTAI | Wiley Matthew T. CHIEF COMMERCIAL OFFICER |
1,008 | $2.6351 | $2,656 | 11,992 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2024-07-22 Option Award |
2025-04-01 6:06 pm |
N/A 2034-07-22 |
BioXcel Therapeutics Inc. | BTAI | Wiley Matthew T. See Remarks |
1,875 | $0 | 1,875 (Direct) |
View |
| 2025-03-17 Option Award |
2025-03-18 4:45 pm |
N/A 2035-03-16 |
Mind Medicine (MindMed) Inc. | MNMD | Wiley Matthew T. Chief Commercial Officer |
350,000 | $0 | 350,000 (Direct) |
View |
| 2024-09-17 Option Award |
2024-10-03 9:55 pm |
N/A N/A |
BioXcel Therapeutics Inc. | BTAI | Wiley Matthew T. Chief Commercial Officer |
21,250 | $0 | 19,011 (Direct) |
View |
| 2024-09-15 Exercise |
2024-09-17 7:18 pm |
N/A N/A |
BioXcel Therapeutics Inc. | BTAI | Wiley Matthew T. Chief Commercial Officer |
750 | $0 | 11,533 (Direct) |
View |
| 2024-06-15 Exercise(A) |
2024-09-17 7:17 pm |
N/A N/A |
BioXcel Therapeutics Inc. | BTAI | Wiley Matthew T. Chief Commercial Officer |
750 | $0 | 8,250 (Direct) |
View |
| 2024-06-15 Exercise |
2024-06-18 9:26 pm |
N/A N/A |
BioXcel Therapeutics Inc. | BTAI | Wiley Matthew T. Chief Commercial Officer |
750 | $0 | 11,748 (Direct) |
View |
| 2024-03-15 Exercise |
2024-04-08 7:31 pm |
N/A N/A |
BioXcel Therapeutics Inc. | BTAI | Wiley Matthew T. CHIEF COMMERCIAL OFFICER |
3,000 | $0 | 11,992 (Direct) |
View |
| 2023-03-15 Option Award |
2023-03-16 5:58 pm |
N/A N/A |
BioXcel Therapeutics Inc. | BTAI | Wiley Matthew T. CHIEF COMMERCIAL OFFICER |
48,000 | $0 | 48,000 (Direct) |
View |
| 2022-01-17 Option Award |
2022-01-19 4:19 pm |
N/A 2032-01-16 |
BioXcel Therapeutics Inc. | BTAI | Wiley Matthew T. CHIEF COMMERCIAL OFFICER |
85,000 | $0 | 85,000 (Direct) |
View |
| 2021-06-30 Tax Withholding |
2021-07-02 4:36 pm |
N/A N/A |
VYNE Therapeutics Inc. | VYNE | Wiley Matthew T. Chief Commercial Officer |
5,151 | $3.51 | 109,246 (Direct) |
View |
| 2021-03-31 Tax Withholding |
2021-04-02 12:15 pm |
N/A N/A |
VYNE Therapeutics Inc. | VYNE | Wiley Matthew T. Chief Commercial Officer |
2,573 | $6.84 | 114,397 (Direct) |
View |
| 2021-02-22 Option Award |
2021-02-24 4:40 pm |
N/A 2031-02-22 |
VYNE Therapeutics Inc. | VYNE | Wiley Matthew T. Chief Commercial Officer |
92,250 | $0 | 181,545 (Direct) |
View |
| 2020-12-31 Tax Withholding |
2021-01-05 4:32 pm |
N/A N/A |
VYNE Therapeutics Inc. | VYNE | Wiley Matthew T. Chief Commercial Officer |
1,541 | $1.58 | 357,181 (Direct) |
View |
| 2020-11-30 Option Award |
2020-12-02 4:31 pm |
N/A N/A |
VYNE Therapeutics Inc. | VYNE | Wiley Matthew T. Chief Commercial Officer |
7,838 | $1.445 | 358,722 (Direct) |
View |
| 2020-09-30 Tax Withholding |
2020-10-02 4:32 pm |
N/A N/A |
VYNE Therapeutics Inc. | VYNE | Wiley Matthew T. Chief Commercial Officer |
1,541 | $1.66 | 350,884 (Direct) |
View |
| 2020-06-30 Tax Withholding |
2020-07-02 4:25 pm |
N/A N/A |
Menlo Therapeutics Inc. | MNLO | Wiley Matthew T. Chief Commercial Officer |
1,541 | $1.73 | 352,425 (Direct) |
View |
| 2020-05-06 Option Award |
2020-05-08 5:54 pm |
N/A 2030-05-06 |
Menlo Therapeutics Inc. | MNLO | Wiley Matthew T. Chief Commercial Officer |
150,000 | $0 | 503,967 (Direct) |
View |